J&J Acquires Halda Therapeutics for $3.05 Billion — A Big Push in Cancer Treatment
Johnson & Johnson (J&J) has signed a $3.05 billion all-cash agreement to acquire Halda Therapeutics, a U.S.-based clinical-stage…
Smart Warriors in Your Blood: Nano-Robots vs Cancer
A Tiny Robot That Could Save Lives Imagine a robot so small that it can travel through your…



































































